Investing.com··GurufocusBecton Dickinson's 13x Valuation Hides Hidden MedTech Growth Engine
$BDX trades at significant discount despite 60% infusion pump dominance, 90%+ recurring revenue, and $4B capital deployment driving billion-dollar growth platforms.
SYKMDTABTBAXBDX+1tariff headwindsvaluation discount